Note 2. Acquisitions The Company makes acquisitions to enhance its capabilities and offerings in certain areas, including technology services. The Company completed four unrelated individually immaterial acquisitions during the first quarter of 2016. These acquisitions expanded the Companys existing capabilities in technology services offerings, and to a lesser degree, information offerings. The purchase price allocations for these acquisitions will be finalized after the completion of the valuation of certain intangible assets and any adjustments to the preliminary purchase price allocation are not expected to have a material impact on the Companys results of operations. The Condensed Consolidated Financial Statements include the results of the acquisitions subsequent to closing. As these acquisitions were immaterial to the Companys operating results both individually and in the aggregate, pro forma results of operations are not provided. The following table provides certain financial information for these acquisitions, including the preliminary allocation of the aggregate purchase price to certain tangible and intangible assets acquired and goodwill. Amortization March 31, (in millions) Period 2016 Total cost of acquisitions, net of cash acquired $ 255 Acquisition-related costs 3 Amounts recorded in the Condensed Consolidated Statements of Financial Position: Goodwill $ 177 Portion of goodwill deductible for tax purposes  Computer software 5-10 years 18 Intangible assets: Client relationships 10 years $ 67 Databases 5 years 28 Trade names 10 years 4 Total intangible assets $ 99 Goodwill is attributable to the value of the synergies between the acquired companies and IMS Health. Cegedim Acquisition In April 2015, the Company completed the acquisition of certain customer relationship management (CRM) and strategic data businesses of Cegedim, SA (Cegedim and the Cegedim acquisition). Cegedim is a global technology and services company specializing in healthcare whose offerings help pharmaceutical compani